Nothing Special   »   [go: up one dir, main page]

WO2002040466A3 - Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders - Google Patents

Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders Download PDF

Info

Publication number
WO2002040466A3
WO2002040466A3 PCT/US2001/051096 US0151096W WO0240466A3 WO 2002040466 A3 WO2002040466 A3 WO 2002040466A3 US 0151096 W US0151096 W US 0151096W WO 0240466 A3 WO0240466 A3 WO 0240466A3
Authority
WO
WIPO (PCT)
Prior art keywords
amidoalkyl
piperidine
piperazine derivatives
treating
disorders
Prior art date
Application number
PCT/US2001/051096
Other languages
French (fr)
Other versions
WO2002040466A2 (en
Inventor
Cheryl P Kordik
Allen B Reitz
Steven J Coats
Chi Luo
Kevin Pan
Michael H Parker
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP2002543477A priority Critical patent/JP2004513944A/en
Priority to KR10-2003-7005908A priority patent/KR20030068547A/en
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Priority to SK611-2003A priority patent/SK6112003A3/en
Priority to EEP200300167A priority patent/EE200300167A/en
Priority to BR0114983-0A priority patent/BR0114983A/en
Priority to IL15558901A priority patent/IL155589A0/en
Priority to AU2002239761A priority patent/AU2002239761A1/en
Priority to NZ525547A priority patent/NZ525547A/en
Priority to CA002427296A priority patent/CA2427296A1/en
Priority to EP01987558A priority patent/EP1334098A2/en
Priority to UA2003054763A priority patent/UA75899C2/en
Priority to MXPA03003817A priority patent/MXPA03003817A/en
Priority to HU0400832A priority patent/HUP0400832A3/en
Publication of WO2002040466A2 publication Critical patent/WO2002040466A2/en
Publication of WO2002040466A3 publication Critical patent/WO2002040466A3/en
Priority to NO20031903A priority patent/NO20031903L/en
Priority to HR20030340A priority patent/HRP20030340A2/en
Priority to BG107789A priority patent/BG107789A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing alicyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/16—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with acylated ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/46—Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives of the general formula wherein all variables are as described herein, useful in the treatment of disorders, such as depression, dementia, schizophrenia, bipolar disorders, anxiety, emesis, acute or neuropathic pain, itching, migraine and movement disorders.
PCT/US2001/051096 2000-10-27 2001-10-23 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders WO2002040466A2 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
HU0400832A HUP0400832A3 (en) 2000-10-27 2001-10-23 New amidoalkyl-piperidine and amidoalkyl-piperazine derivatives, and pharmaceutical compositions containing such derivatives as active ingredients
NZ525547A NZ525547A (en) 2000-10-27 2001-10-23 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous system disorders
SK611-2003A SK6112003A3 (en) 2000-10-27 2001-10-23 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for the treatment of nervous system disorders
EEP200300167A EE200300167A (en) 2000-10-27 2001-10-23 Amidoalkylpiperidine and Piperazine Derivatives, Pharmaceutical Composition Containing Them, and Use of Compounds for the Treatment of Nervous System Disorders
BR0114983-0A BR0114983A (en) 2000-10-27 2001-10-23 Amidoalkyl piperidine and amidoalkyl piperazine derivatives useful for treating nervous system disorders
IL15558901A IL155589A0 (en) 2000-10-27 2001-10-23 Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
AU2002239761A AU2002239761A1 (en) 2000-10-27 2001-10-23 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders
JP2002543477A JP2004513944A (en) 2000-10-27 2001-10-23 Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for treating nervous system disorders
CA002427296A CA2427296A1 (en) 2000-10-27 2001-10-23 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders
UA2003054763A UA75899C2 (en) 2000-10-27 2001-10-23 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives, useful in the treatment of nervous system disorders
EP01987558A EP1334098A2 (en) 2000-10-27 2001-10-23 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders
MXPA03003817A MXPA03003817A (en) 2000-10-27 2001-10-23 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders.
KR10-2003-7005908A KR20030068547A (en) 2000-10-27 2001-10-23 Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
NO20031903A NO20031903L (en) 2000-10-27 2003-04-28 New amidoalkylpiperidine and amidoalkylpiperazine derivatives for use in the treatment of nervous system disorders
HR20030340A HRP20030340A2 (en) 2000-10-27 2003-04-29 Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
BG107789A BG107789A (en) 2000-10-27 2003-05-09 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24411700P 2000-10-27 2000-10-27
US60/244,117 2000-10-27

Publications (2)

Publication Number Publication Date
WO2002040466A2 WO2002040466A2 (en) 2002-05-23
WO2002040466A3 true WO2002040466A3 (en) 2002-08-29

Family

ID=22921433

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/051096 WO2002040466A2 (en) 2000-10-27 2001-10-23 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders

Country Status (24)

Country Link
US (2) US20020183316A1 (en)
EP (1) EP1334098A2 (en)
JP (1) JP2004513944A (en)
KR (1) KR20030068547A (en)
CN (1) CN1483030A (en)
AU (1) AU2002239761A1 (en)
BG (1) BG107789A (en)
BR (1) BR0114983A (en)
CA (1) CA2427296A1 (en)
CZ (1) CZ20031386A3 (en)
EE (1) EE200300167A (en)
HR (1) HRP20030340A2 (en)
HU (1) HUP0400832A3 (en)
IL (1) IL155589A0 (en)
MX (1) MXPA03003817A (en)
NO (1) NO20031903L (en)
NZ (1) NZ525547A (en)
PL (1) PL361947A1 (en)
RU (1) RU2003115612A (en)
SK (1) SK6112003A3 (en)
TW (1) TWI258476B (en)
UA (1) UA75899C2 (en)
WO (1) WO2002040466A2 (en)
ZA (1) ZA200304064B (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7655658B2 (en) 2001-08-10 2010-02-02 Palatin Technologies, Inc. Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds
WO2003013571A1 (en) 2001-08-10 2003-02-20 Palatin Technologies, Inc. Peptidomimetics of biologically active metallopeptides
US7354923B2 (en) 2001-08-10 2008-04-08 Palatin Technologies, Inc. Piperazine melanocortin-specific compounds
US7718802B2 (en) 2001-08-10 2010-05-18 Palatin Technologies, Inc. Substituted melanocortin receptor-specific piperazine compounds
US7732451B2 (en) 2001-08-10 2010-06-08 Palatin Technologies, Inc. Naphthalene-containing melanocortin receptor-specific small molecule
US7456184B2 (en) 2003-05-01 2008-11-25 Palatin Technologies Inc. Melanocortin receptor-specific compounds
GB0218326D0 (en) * 2002-08-07 2002-09-11 Glaxo Group Ltd Compounds
US7968548B2 (en) 2003-05-01 2011-06-28 Palatin Technologies, Inc. Melanocortin receptor-specific piperazine compounds with diamine groups
US7727991B2 (en) 2003-05-01 2010-06-01 Palatin Technologies, Inc. Substituted melanocortin receptor-specific single acyl piperazine compounds
US7727990B2 (en) 2003-05-01 2010-06-01 Palatin Technologies, Inc. Melanocortin receptor-specific piperazine and keto-piperazine compounds
US20050124625A1 (en) * 2003-10-21 2005-06-09 Salvati Mark E. Piperazine derivatives and their use as modulators of nuclear hormone receptor function
US7709484B1 (en) 2004-04-19 2010-05-04 Palatin Technologies, Inc. Substituted melanocortin receptor-specific piperazine compounds
US7598249B2 (en) 2004-12-30 2009-10-06 Janssen Pharmaceutica N.V. Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase
WO2007099828A1 (en) 2006-02-23 2007-09-07 Shionogi & Co., Ltd. Nirogenous heterocyclic derivatives substituted with cyclic groups
US7834017B2 (en) 2006-08-11 2010-11-16 Palatin Technologies, Inc. Diamine-containing, tetra-substituted piperazine compounds having identical 1- and 4-substituents
NZ575624A (en) 2006-10-18 2012-02-24 Pfizer Prod Inc Biaryl ether urea compounds
WO2008140198A1 (en) 2007-05-14 2008-11-20 Sk Holdings Co., Ltd. Novel carbamoyloxy arylalkanoyl arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
US20090325964A1 (en) * 2008-05-23 2009-12-31 Wyeth Piperazine Metabotropic Glutamate Receptor 5 (MGLUR5) Negative Allosteric Modulators For Anxiety/Depression
UA108233C2 (en) 2010-05-03 2015-04-10 Fatty acid amide hydrolysis activity modulators
HU230744B1 (en) 2012-11-30 2018-01-29 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Novel process for preparing travoprost
KR101796390B1 (en) 2015-07-24 2017-11-09 동국대학교 산학협력단 Novel compound having BLT-inhibitory activity and composition for preventing or treating inflammatory diseases comprising the same as an active ingredient
WO2017018750A1 (en) * 2015-07-24 2017-02-02 동국대학교 산학협력단 Novel compound having blt inhibitory activity and composition, for preventing or treating inflammatory diseases, comprising same as active ingredient
MX2019000536A (en) 2016-07-14 2019-04-01 Pfizer Novel pyrimidine carboxamides as inhibitors of vanin-1 enzyme.
WO2018135918A1 (en) * 2017-01-23 2018-07-26 동국대학교 산학협력단 Pharmaceutical composition comprising compound having blt inhibiting activity as effective ingredient for preventing or treating chronic obstructive pulmonary disease

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0071433A1 (en) * 1981-07-28 1983-02-09 Kowa Company, Ltd. Medicine for the treatment of diabetes
US4746737A (en) * 1985-07-26 1988-05-24 Kowa Co., Ltd. Phenyl guanidinobenzoate derivatives which have protease inhibitory activity
EP0377457A1 (en) * 1989-01-05 1990-07-11 Fujisawa Pharmaceutical Co., Ltd. Thiazole compounds, processes for the preparation thereof, and pharmaceutical composition comprising the same
EP0496378A1 (en) * 1991-01-24 1992-07-29 Dr. Karl Thomae GmbH Biphenylderivatives, drugs containing these compounds and processes for their preparation
US5525623A (en) * 1993-03-12 1996-06-11 Arris Pharmaceutical Corporation Compositions and methods for the treatment of immunomediated inflammatory disorders
FR2744449A1 (en) * 1996-02-02 1997-08-08 Pf Medicament NOVEL AROMATIC PIPERAZINES DERIVED FROM SUBSTITUTED CYCLOAZANES, AS WELL AS THE PROCESS FOR PREPARING THEM, PHARMACEUTICAL COMPOSITIONS AND THEIR USE AS MEDICAMENTS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3601397A1 (en) * 1986-01-18 1987-07-23 Bayer Ag SUBSTITUTED 1,4-DIHYDROPYRIDIN-3-CARBONIC ACID PIPERAZIDES, METHOD FOR THE PRODUCTION AND THEIR USE IN MEDICINAL PRODUCTS
US5892039A (en) * 1995-08-31 1999-04-06 Schering Corporation Piperazino derivatives as neurokinin antagonists

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0071433A1 (en) * 1981-07-28 1983-02-09 Kowa Company, Ltd. Medicine for the treatment of diabetes
US4746737A (en) * 1985-07-26 1988-05-24 Kowa Co., Ltd. Phenyl guanidinobenzoate derivatives which have protease inhibitory activity
EP0377457A1 (en) * 1989-01-05 1990-07-11 Fujisawa Pharmaceutical Co., Ltd. Thiazole compounds, processes for the preparation thereof, and pharmaceutical composition comprising the same
EP0496378A1 (en) * 1991-01-24 1992-07-29 Dr. Karl Thomae GmbH Biphenylderivatives, drugs containing these compounds and processes for their preparation
US5525623A (en) * 1993-03-12 1996-06-11 Arris Pharmaceutical Corporation Compositions and methods for the treatment of immunomediated inflammatory disorders
FR2744449A1 (en) * 1996-02-02 1997-08-08 Pf Medicament NOVEL AROMATIC PIPERAZINES DERIVED FROM SUBSTITUTED CYCLOAZANES, AS WELL AS THE PROCESS FOR PREPARING THEM, PHARMACEUTICAL COMPOSITIONS AND THEIR USE AS MEDICAMENTS

Also Published As

Publication number Publication date
EP1334098A2 (en) 2003-08-13
AU2002239761A1 (en) 2002-05-27
RU2003115612A (en) 2004-12-27
BG107789A (en) 2004-02-27
CZ20031386A3 (en) 2004-02-18
IL155589A0 (en) 2003-11-23
HUP0400832A3 (en) 2004-10-28
EE200300167A (en) 2003-08-15
TWI258476B (en) 2006-07-21
PL361947A1 (en) 2004-10-18
JP2004513944A (en) 2004-05-13
HUP0400832A2 (en) 2004-07-28
BR0114983A (en) 2003-09-23
HRP20030340A2 (en) 2005-04-30
MXPA03003817A (en) 2004-10-15
NO20031903D0 (en) 2003-04-28
US20050004136A1 (en) 2005-01-06
UA75899C2 (en) 2006-06-15
NO20031903L (en) 2003-06-25
KR20030068547A (en) 2003-08-21
US20020183316A1 (en) 2002-12-05
CN1483030A (en) 2004-03-17
WO2002040466A2 (en) 2002-05-23
NZ525547A (en) 2004-11-26
ZA200304064B (en) 2004-08-26
SK6112003A3 (en) 2004-04-06
CA2427296A1 (en) 2002-05-23

Similar Documents

Publication Publication Date Title
WO2002040466A3 (en) Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders
MXPA04000622A (en) Pyrazolylcarboxanilides as fungicides.
MXPA02008056A (en) 2 oxo 1 pyrrolidine derivatives, processes for preparing them and their uses.
CN104059013B8 (en) 1-aryl-3-azabicyclo [3.1.0] hexane: its preparation method and for treating the purposes of neuropsychiatric disorders
ES2194960T3 (en) N- (2-SUBSTITUTED-3- (2-AMINOETIL) -1H-INDOL-5-IL) -AMIDAS AS NEW AGONISTS OF 5-HT1F.
WO2004054501A3 (en) Methods of usig and compositions comprising (-)-3-(3,4-dimethoxy-phenyl)-3-(1-oxo-1,3-dihydro-isoindol-2-yl)-propionamide
WO1999054326A8 (en) Dihydropyrimidines
WO2006122186A3 (en) 1,4-diphenyl-3-hydroxyalkyl-2-azetidinone derivatives for treating hypercholestrolemia
NZ544591A (en) Pyrrolodihydroisoquinolines as PDE10 inhibitors
GEP20053660B (en) Novel Tyrosine Kinase Inhibitors
NZ595571A (en) Pyrazole compounds and uses thereof
AU5426699A (en) Phosphohalohydrins, method for making same and uses
NZ523314A (en) Bis-arylsulfones
WO2002088127A3 (en) Triazolopyrimidines
CA2415354A1 (en) Phospholipid derivatives of valproic acid and mixtures thereof
EP1078936A3 (en) Process for stripping polymer dispersions or solutions
BR0017157A (en) 6-hydroxy-indazole derivatives for the treatment of glaucoma
WO2003042173A8 (en) Nk1 antagonists
TR200402670T4 (en) Method for finding compounds suitable for the treatment and / or prophylaxis of obesity
MXPA02009549A (en) Tricyclic imidazopyridines.
AU2003215190A8 (en) Methods and compositions for treating aids and hiv-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules.
AU5426599A (en) Phosphoepoxides, method for making same and uses
PT1254905E (en) 4- (2-PYRIDYL) PIPERIZINES HAVING AGRONIST ACTIVITY OF 5HT7 RECEPTOR
NZ335052A (en) Piperazino derivatives as neurokinin antagonists
NZ511997A (en) Isonipecotamides for the treatment of integrin-mediated disorders

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 155589

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: PA/a/2003/003817

Country of ref document: MX

Ref document number: 527/KOLNP/2003

Country of ref document: IN

Ref document number: 1-2003-500301

Country of ref document: PH

Ref document number: 1020037005908

Country of ref document: KR

Ref document number: 2427296

Country of ref document: CA

Ref document number: 2002239761

Country of ref document: AU

Ref document number: 2002543477

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: P20030340A

Country of ref document: HR

Ref document number: 525547

Country of ref document: NZ

ENP Entry into the national phase

Ref document number: 10778901

Country of ref document: BG

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: PV2003-1386

Country of ref document: CZ

WWE Wipo information: entry into national phase

Ref document number: 6112003

Country of ref document: SK

Ref document number: 03042548

Country of ref document: CO

WWE Wipo information: entry into national phase

Ref document number: 2003/04064

Country of ref document: ZA

Ref document number: 200304064

Country of ref document: ZA

ENP Entry into the national phase

Ref country code: RU

Ref document number: RU A

Ref document number: 2003115612

Country of ref document: RU

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2001987558

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 018213936

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 2001987558

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1020037005908

Country of ref document: KR

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: PV2003-1386

Country of ref document: CZ

WWP Wipo information: published in national office

Ref document number: 525547

Country of ref document: NZ

WWG Wipo information: grant in national office

Ref document number: 525547

Country of ref document: NZ

WWW Wipo information: withdrawn in national office

Ref document number: 2001987558

Country of ref document: EP